Head-to-head · Value Score
CoreAge Rx vs Henry Meds
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Henry Meds a 78. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameHenry Meds
#23 · Grade B- · Fair Price
Est. first month
$249/mo
Save ~82% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 78 — an est. $149/mo first month, with no teaser step-up baked in. Henry Meds isn't out of it: People who want a simple, well-known flat-fee program and will pay a premium for it.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Henry Meds |
|---|---|---|
| Value Score | 93 (A+) | 78 (B-) |
| Est. first month | $149/mo | $249/mo |
| Save vs brand-name | ~89% | ~82% |
| Semaglutide | $149/mo | $249/mo |
| Tirzepatide | $349/mo | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Henry Meds
The flat-fee pioneer: honest, no step-ups — just priced at the higher end of the market now.
Why it's a deal
- Simple flat-fee model with no teaser step-ups
- Well-established brand
- Both molecules
The fine print
- Higher pricing than most newer entrants
- Compounded only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.